I can't get specifically into that matter, but generally speaking, when the CEPA process did the review, going back some years ago, of in-commerce substances, they did an assortment based on highest risk, medium risk and lowest risk, and they batched the highest risk and did the assessments. That process worked very well. It was very efficient, probably one of the most efficient evaluations of in-commerce substances in the world. I would think there is probably guidance to be gleaned from the definitions that were used to set up that initial list as to what was the highest level of concern, the medium level of concern and the lower level of concern with substances.
On December 6th, 2022. See this statement in context.